Soderzhanie androgenov u zhenshchin s gipogonadotropnym gipogonadizmom



  1. Bachmann G, Bancrofti J, Braunstein G et al. Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment. Fertil Steril 2002; 77: 660-5.
  2. Labrie F, Belanger A, Cusan L et al. Marked decline in serum concentrations of adrenal C19 sex precursors and conjugated androgen metabolites during aging. J Clin Endocrinol Metab 1997; 82: 2396-402.
  3. Zuckerman-Levin N, Frolova-Bishara T, Militianu D et al. Androgen replacement therapy in Turner syndrome: a pilot study. J Clin Endocrinol Metab 2009; 94 (12): 4820-7.
  4. Arlt W, Callies F, van Vlijmen J et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 1999, 341: 1013-20.
  5. Davey DA. Androgens in women before and after the menopause and post bilateral oophorectomy: clinical effects and indications for testosterone therapy. Womens Health (Lond Engl) 2012; 8 (4): 437-46.
  6. Erichsen MM, Husebye ES, Michelsen TM et al. Sexuality and fertility in women with Addison's disease. J Clin Endocrinol Metab 2010; 95 (9): 4354-60.
  7. Kratz A, Ferraro M, Sluss P, Lewandrowski K. Laboratory reference values. N Engl J Med 2004, 351: 1548-63.
  8. Fonseca HP, Scapinelli A, Aoki T, Aldrighi JM. Female androgen deficiency. Rev Assoc Med Bras 2010; 56 (5): 579-82.
  9. Guay AT. Screening for androgen deficiency in women: methodological and interpretive issues. Fertil Steril 2002; 77: 83-8.
  10. Davison SL. Hypoactive sexual desire disorder. Curr Opin Obstet Gynecol 2012; 24 (4): 215-20.
  11. Fischli S, Jenni S, Allemann S et al. Dehydroepiandrosterone sulfate in the assessment of the hypothalamic-pituitary-adrenal axis. J Clin Endocrinol Metab 2008; 93 (2): 539-42.
  12. Miller K, Sesmilo G, Schiller A et al. Androgen deficiency in women with hypopituitarism. J Clin Endocrinol Metab 2001, 86: 561-7.
  13. Zborowski JV, Cauley JA, Talbott EO et al. Bone mineral density, androgens, and the polycystic ovary: the complex and controversial issue of androgenic influence in female bone. J Clin Endocrinol Metab 2000; 85: 3496-506.
  14. Waaseth M, Bakken K, Dumeaux V et al. Hormone replacement therapy use and plasma levels of sex hormones in the Norwegian Women and Cancer postgenome cohort - a cross-sectional analysis. BMC Womens Health 2008; 14 (8): 1.
  15. Ali I, James T, Meston N et al. Age and hormone replacement therapy as factors influencing androgen levels in the postmenopausal female. Clin Chem Lab Med 2009; 47 (2): 202-7.
  16. Miller KK, Biller BMK, Beauregard C et al. Effects of Testosterone Replacement in Androgen-Deficient Women with Hypopituitarism: A Randomized, Double-Blind, Placebo-Controlled Study. J Clin Endocrinol Metab 2006; 91: 1683-90.

Copyright (c) 2012 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС77-63961 от 18.12.2015.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies